PharmaEssentia Corporation (LUX:261280523)

PharmaEssentia Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	21,581	21,051	19,666	10,304	3,454	3,200
Short-Term Investments	0.43	-	-	-	-	12
Cash & Short-Term Investments	21,582	21,051	19,666	10,304	3,454	3,212
Cash Growth	3.60%	7.04%	90.86%	198.34%	7.51%	130.17%
Accounts Receivable	3,558	2,624	1,312	798.87	466.04	450.6
Other Receivables	199.97	208.01	236.08	41.22	27.17	2.74
Receivables	3,758	2,832	1,548	840.09	493.22	453.34
Inventory	1,182	1,287	1,459	1,102	861.38	394.85
Prepaid Expenses	247.42	163.58	151.92	55.64	49.02	43.95
Other Current Assets	72.44	83.63	71.18	1,074	69.41	42.91
Total Current Assets	26,842	25,417	22,896	13,375	4,927	4,147
Property, Plant & Equipment	4,035	3,361	2,733	1,018	764.93	891.66
Long-Term Investments	471.64	542.44	163.92	43.24	39.22	95.23
Other Intangible Assets	244.53	272.72	267.91	236.88	246.25	220.65
Long-Term Deferred Tax Assets	1,982	1,120	958.46	483.42	-	-
Other Long-Term Assets	874.6	347.95	249.72	176.38	221.13	176.22
Total Assets	34,450	31,062	27,269	15,333	6,198	5,531
Accounts Payable	200.34	126.47	128.88	230.96	176.38	177.07
Accrued Expenses	1,535	1,106	970.52	667.45	405.5	275.37
Short-Term Debt	-	-	21	993.88	20	50
Current Portion of Long-Term Debt	7.07	11.9	12.36	12.14	12.05	6.5
Current Portion of Leases	204.51	180.56	211.85	77.76	78.59	90.27
Current Income Taxes Payable	66.15	-	0.99	-	-	-
Current Unearned Revenue	-	0.23	-	-	-	-
Other Current Liabilities	1,915	1,132	806.49	568.16	719.44	487.5
Total Current Liabilities	3,928	2,557	2,152	2,550	1,412	1,087
Long-Term Debt	46.33	50.81	62.71	74.98	87.09	99.2
Long-Term Leases	635.09	722.16	892.29	410.05	338.51	400.76
Pension & Post-Retirement Benefits	9.08	11.06	10.21	4.18	3.95	4.03
Long-Term Deferred Tax Liabilities	69.73	81.32	105.96	8.22	-	-
Other Long-Term Liabilities	12.13	170.21	97.91	143.64	106.3	20.79
Total Liabilities	4,701	3,593	3,321	3,191	1,948	1,611
Common Stock	3,422	3,418	3,403	3,025	2,769	2,634
Additional Paid-In Capital	23,592	23,547	24,092	13,421	4,697	3,727
Retained Earnings	5,769	2,974	-631.19	-4,186	-2,811	-2,144
Treasury Stock	-2,805	-2,805	-2,805	-87.5	-344.74	-257.24
Comprehensive Income & Other	-228.02	335.89	-110.37	-31.54	-60.15	-40.44
Shareholders' Equity	29,749	27,469	23,948	12,141	4,250	3,920
Total Liabilities & Equity	34,450	31,062	27,269	15,333	6,198	5,531
Total Debt	892.99	965.43	1,200	1,569	536.24	646.73
Net Cash (Debt)	20,689	20,086	18,466	8,735	2,917	2,566
Net Cash Growth	4.44%	8.77%	111.40%	199.41%	13.71%	164.17%
Net Cash Per Share	55.75	54.18	51.60	27.70	10.10	9.54
Filing Date Shares Outstanding	333.28	369.42	367.72	334.64	303.03	289.07
Total Common Shares Outstanding	333.28	369.42	367.72	334.64	303.03	289.07
Working Capital	22,914	22,860	20,744	10,825	3,515	3,061
Book Value Per Share	89.26	74.36	65.13	36.28	14.03	13.56
Tangible Book Value	29,505	27,196	23,680	11,904	4,004	3,699
Tangible Book Value Per Share	88.53	73.62	64.40	35.57	13.21	12.80
Land	58.24	58.24	58.24	58.24	58.24	58.24
Buildings	69.82	70.86	70.63	70.61	70.52	70.54
Machinery	857.85	811.38	723.26	534.93	486.58	442.21
Construction In Progress	2,710	2,011	1,188	234.56	36.49	42.56
Leasehold Improvements	496.26	429.87	426.29	371.12	341.61	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.